Abstract
Oseltamivir-Resistant Pandemic (H1N1) 2009 Treated with Nebulized Zanamivir
Highlights
Neurologic complications associated with novel influenza A (H1N1) virus infection in children, Dallas, Texas, May 2009
Zanamivir represents the therapeutic option for patients infected with the H275Y mutation of pandemic (H1N1) 2009 virus
Successful use of intravenous zanamivir in a critically ill child, who was immunosuppressed after allogenic stem cell transplantation and infected with oseltamivir-resistant pandemic (H1N1) 2009 virus, has been reported (6)
Summary
Neurologic manifestations of pandemic (H1N1) 2009 virus infection. Neurologic complications associated with novel influenza A (H1N1) virus infection in children, Dallas, Texas, May 2009. Severe encephalopathy with swine origin influenza A H1N1 infection in childhood: case reports.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
